Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia

FDA Approves Novel Treatment for Hairy Cell Leukemia

0
Lumoxiti, a CD22-directed cytotoxin, approved for adults who have had at least two prior therapies
Calling the use of electronic cigarettes a burgeoning epidemic among teens

FDA Gets Tough on Juul, Other Electronic Cigarette Makers

0
More than 1,200 warning letters and fines have been sent to retailers and major e-cigarette manufacturers
Cassipa (buprenorphine and naloxone)

FDA Approves New Treatment for Opioid Dependence

0
The sublingual buprenorphine and naloxone combo should be part of a complete treatment plan
Four more online networks that operate 21 websites illegally selling potentially dangerous

FDA Warning Letters Target Illegal Online Sales of Opioids

0
Medications may be counterfeit, contaminated, expired, or otherwise unsafe
Hundreds of Dr. King's water-based homeopathic drugs for children

FDA: Hundreds of Human, Pet Homeopathy Products Recalled

0
King Bio recalls number of water-based products due to high levels of microbial contamination
Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic keratitis

FDA Approves First Drug for Neurotrophic Keratitis

0
Oxervate, a topical eye drop, led to complete corneal healing among 70 percent of study participants
Potentially poisonous electronic cigarette liquid made by 17 different manufacturers comes in packaging that strongly resembles that of candies

FDA Bans E-Cig Liquid Products That Look Like Snacks, Candies

0
Labels and ads for the nicotine-containing e-liquids were false or misleading, and potentially dangerous
The first generic version of the EpiPen has been approved by the U.S. Food and Drug Administration

FDA Approves First Generic EpiPen

0
Approval will address both rising costs and shortages of epinephrine
A brain stimulation device to treat obsessive-compulsive disorder has received approval for marketing by the U.S. Food and Drug Administration.

FDA Permits Marketing of Brain Stimulation Device for OCD

0
FDA previously approved transcranial magnetic stimulation for major depression, certain migraines
Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.

FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma

0
Drug approved to treat relapsed or refractory mycosis fungoides and Sézary syndrome